Sort
21,281 grants matching “influenza”
Small molecule inhibitors of enveloped virus entry
$4,422,325Sean P. J. Whelan · Harvard Medical School · U19 · FY2014 · AI
Centers of Excellence for Influenza Research and Surveillance
$4,419,345John Jay Treanor · University Of Rochester · N01 · FY2012 · AI
Systems Biological Analysis of Innate and Adaptive Responses to Vaccination
$4,398,252Bali Pulendran · Emory University · U19 · FY2011 · AI
Development and Production of SARS-CoV2 Biologicals and Vaccines
$4,391,926Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2022 · AI
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
$4,386,974Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2020 · AI
Stat transcription factors in immunoregulation and autoimmune disease
$4,374,543John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR
Emerging Infections Program
$4,364,715Guthrie S Birkhead · Nysdoh/Health Research, Inc. · U01 · FY2010 · CI
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,362,911Gerard Zurawski · Baylor Research Institute · U19 · FY2013 · AI
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
$4,359,363Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2018 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core
$4,351,463Wendell Beres · Duke University · N01 · FY2025 · AI
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
$4,346,579Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2023 · AI
Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 hospitalized pa
$4,325,153Marla J Keller · Albert Einstein College Of Medicine · UL1 · FY2020 · TR
Centers of Excellence for Influenza Research and Surveillance
$4,323,483John Jay Treanor · University Of Rochester · N01 · FY2011 · AI
Biodefense and Emerging Infectious Disease and Influenza Vaccine Studies
$4,323,375Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Multiplexed POC Diagnostic System for Bio-Threat Agents
$4,309,573Meso Scale Diagnostics, Llc · UC1 · FY2005 · AI
Bioinformatics Resource Center
$4,308,273Richard H Scheuermann · · N01 · FY2013 · AI
Influenza Vaccine Research and Development
$4,307,191Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Resources, Workforce Development, and Animal Models for the Rutgers RBL
$4,302,711David Alland · Rutgers Biomedical And Health Sciences · UC7 · FY2025 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH
$4,300,891Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2021 · AI
Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection
$4,299,740Mark M Davis · Stanford University · U19 · FY2015 · AI
Emerging Infections Program
$4,294,655Dale L Morse · Nysdoh/Health Research, Inc. · U01 · FY2008 · CI
Pandemic Influenza Translational Research; Novel Vaccine and Drug Therapy
$4,294,600Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Influenza Vaccine Research and Development
$4,261,000Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Centers of Excellence for Influenza Research and Surveillance
$4,258,370John Jay Treanor · · N01 · FY2013 · AI
Biodefense/Emerging Infection Vaccine Studies
$4,251,944Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI